Suppr超能文献

[基于多轮粪便免疫化学检测的中国人群结直肠癌筛查中结直肠肿瘤的参与率及检测情况]

[Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].

作者信息

Li N, Zhou Y Y, Lu M, Zhang Y H, Lu B, Luo C Y, Luo J H, Cai J, Chen H D, Dai M

机构信息

Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.

Center for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2023 Dec 23;45(12):1041-1050. doi: 10.3760/cma.j.cn112152-20230221-00073.

Abstract

To evaluate the participation rate and detection of colorectal neoplasms based on annual fecal immunochemical testing (FIT) for three consecutive years in a population-based colorectal cancer screening program in China. Based on a population-based colorectal cancer screening program conducted from May 2018 to May 2021 in 6 centers in China, 7 793 eligible participants aged 50-74 were included and offered free FIT and colonoscopy (for those who were FIT-positive on initial screening). At baseline, all participants were invited to receive FIT. In subsequent screening rounds, only FIT-positive participants who did not undergo colonoscopy or FIT-negative participants were invited to have repeated FIT screening. FIT-positive participants were recommended to undertake colonoscopy and pathological examination (if abnormalities were found during colonoscopy). An overall of three rounds of annual FIT screening were conducted. The primary outcomes of the study were the participation rate of FIT screening, the compliance rate of colonoscopy for FIT-positive participants, and the detection rate of colorectal neoplasms. Among the 7 793 participants included in this study, 3 310 (42.5%) were male, with age of (60.50±6.49) years. The overall participation rates for the first, second and third round of FIT screening were 94.0%(7 327/7 793), 86.8% (6 048/6 968) and 91.3% (6 113/6 693), respectively. Overall, 7 742 out of 7 793 participants (99.3%) attended at least one round of screening, and 5 163 out of 7 793 participants (66.3%) attended all three rounds of screening. The positivity rate was significantly higher in the first (14.6%, 1 071/7 327) round compared with the second (5.6%, 3 41/6 048) and third (5.5%, 3 39/6 113) screening rounds (<0.001). The overall compliance rates of colonoscopy examination among FIT-positive subjects were over 70% in three rounds, which were 76.3% (817/1 071), 75.7% (258/341) and 71.7% (243/339), respectively. In a multivariate logistic regression model considering factors including sex, education background, smoking, alcohol drinking, previous colonoscopy examination, colonic polyp history and family history of colorectal cancer among first-degree relatives, gender and smoking status were related factors affecting the participation rate of FIT screening, with higher rate in males and non-smokers. In addition, logistic regression analysis also found that age was negatively correlated with the compliance rate of colonoscopy in FIT positive patients. The detection rate of advanced tumors (colorectal cancer + advanced adenoma) declined from the first round to subsequent rounds [1st round: 1.15% (90/7 793); 2nd round: 0.57% (40/6 968); and 3rd round: 0.58% (39/6 693)], however, the positive predictive value for advanced neoplasms increased round by round, and was 11.02% in the first screening round, 15.50% in the second screening round, and 16.05 % in the third screening round. In each screening round, the detection rate for advanced neoplasms was higher in men than that in women, and increased with age. Annual repeated FIT screening has high acceptance and satisfying detection rates in the Chinese population. To optimize and improve the effectiveness of colorectal cancer screening, multi-round repeated FIT screening should be implemented while ensuring high participation rates.

摘要

在中国一项基于人群的结直肠癌筛查项目中,评估连续三年进行年度粪便免疫化学检测(FIT)时结直肠肿瘤的参与率和检出情况。基于2018年5月至2021年5月在中国6个中心开展的一项基于人群的结直肠癌筛查项目,纳入了7793名年龄在50 - 74岁的符合条件的参与者,并为他们提供免费FIT检测和结肠镜检查(针对初筛FIT呈阳性者)。在基线时,所有参与者均被邀请接受FIT检测。在随后的筛查轮次中,仅邀请未接受结肠镜检查的FIT阳性参与者或FIT阴性参与者进行重复FIT筛查。FIT阳性参与者被建议进行结肠镜检查及病理检查(若在结肠镜检查中发现异常)。总共进行了三轮年度FIT筛查。该研究的主要结局为FIT筛查的参与率、FIT阳性参与者的结肠镜检查依从率以及结直肠肿瘤的检出率。在本研究纳入的7793名参与者中,3310名(42.5%)为男性,年龄为(60.50±6.49)岁。FIT筛查第一轮、第二轮和第三轮的总体参与率分别为94.0%(7327/7793)、86.8%(6048/6968)和91.3%(6113/6693)。总体而言,7793名参与者中有7742名(99.3%)至少参加了一轮筛查,7793名参与者中有5163名(66.3%)参加了全部三轮筛查。第一轮筛查的阳性率(14.6%,1071/7327)显著高于第二轮(5.6%,341/6048)和第三轮(5.5%,339/6113)(<0.001)。FIT阳性受试者的结肠镜检查总体依从率在三轮中均超过70%,分别为76.3%(817/1071)、75.7%(258/341)和71.7%(243/339)。在一个多因素逻辑回归模型中,考虑性别、教育背景、吸烟、饮酒、既往结肠镜检查、结肠息肉病史以及一级亲属结直肠癌家族史等因素,性别和吸烟状态是影响FIT筛查参与率的相关因素,男性和非吸烟者的参与率较高。此外,逻辑回归分析还发现年龄与FIT阳性患者的结肠镜检查依从率呈负相关。晚期肿瘤(结直肠癌 + 高级别腺瘤)的检出率从第一轮至后续轮次呈下降趋势[第一轮:1.15%(90/7793);第二轮:0.57%(40/6968);第三轮:0.58%(39/6693)],然而,晚期肿瘤的阳性预测值逐轮增加,在第一轮筛查中为11.02%,第二轮筛查中为15.50%,第三轮筛查中为16.05%。在每一轮筛查中,男性晚期肿瘤的检出率均高于女性,且随年龄增加而升高。年度重复FIT筛查在中国人群中具有较高的接受度和令人满意的检出率。为优化和提高结直肠癌筛查的效果,应在确保高参与率的同时实施多轮重复FIT筛查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验